Tarloxotinib Uses, Dosage, Side Effects and more
Tarloxotinib is under investigation in clinical trial NCT03743350 (NSCLC Exon 20 or HER2-activating Mutations).
| Trade Name | Tarloxotinib |
| Generic | Tarloxotinib |
| Type | |
| Formula | C24H24BrClN9O3 |
| Weight | Average: 601.87 Monoisotopic: 600.086853 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
